Atypical meningioma has been introduced as tumour subtype of intermedi
ate biological behaviour between classical and malignant meningiomas.
To substantiate this three-step scale of malignancy, we assessed the p
roliferative activity reflected by Ki-67 (MIB1) labelling index (LI) i
n a series of 89 meningiomas, including 15 classical, 29 atypical, 35
anaplastic tumours, and 10 haemangiopericytomas and papillary meningio
mas. The possible correlation of proliferation with the frequency of a
poptosis and their relations to BCL-2 immunoexpression was investigate
d in seven classical, 10 atypical and 10 malignant meningiomas. Apopto
sis was demonstrated by evaluation of the frequency of apoptotic figur
es, by the enzymatic technique of in situ tailing (IST) which stains a
poptotic DNA fragments, and by DNA preparation and gel electrophoresis
demonstrating DNA laddering in frozen tissues of five meningiomas. MI
B1 LI revealed a highly significant increase from classical through at
ypical to anaplastic meningiomas (P < 0.0001); haemangiopericytomas an
d papillary meningiomas were well within the range of atypical meningi
omas. IST indices rose with increasing malignancy and correlated with
MIB1 LI (P < 0.0001); they showed a weak inverse correlation with BCL-
2 immunoexpression (P = 0.05), BCL-2 expression tended to decrease wit
h malignancy grade and was unrelated to MIB1 LI or frequency of apopto
sis. Our data show that (i) apoptosis is a feature of meningiomas, sig
nificantly correlated with the malignancy scale, (ii) DNA fragmentatio
n shows significant correlation with proliferation and inversely with
BCL-2 expression; (iii) proliferation indices and frequencies of apopt
osis/DNA fragmentation within meningioma subgroups corroborate the int
ermediate biological position of the atypical meningioma between class
ical and malignant meningiomas.